Cypress Capital’s Eli Lilly LLY Stock Holding History

Cypress Capital’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$895K	Sell	746 -6	-0.8%	-$6.13K	0.24%	59
2026 Q1	$692K	Buy	752 +3	+0.4%	+$3.04K	0.2%	58
2025 Q4	$805K	Sell	749 -43	-5%	-$41.1K	0.23%	55
2025 Q3	$604K	Buy	792 +114	+17%	+$84.8K	0.17%	66
2025 Q2	$529K	Buy	678 +169	+33%	+$131K	0.15%	62
2025 Q1	$420K	Sell	509 -73	-13%	-$60.7K	0.12%	67
2024 Q4	$449K	Buy	582 +11	+2%	+$9.11K	0.13%	60
2024 Q3	$506K	Sell	571 -513	-47%	-$461K	0.13%	61
2024 Q2	$981K	Buy	1,084 +555	+105%	+$444K	0.25%	52
2024 Q1	$412K	Buy	529 +2	+0.4%	+$1.42K	0.11%	64
2023 Q4	$307K	Sell	527 -32	-6%	-$18.7K	0.09%	68
2023 Q3	$300K	Buy	559 +3	+0.5%	+$1.55K	0.09%	66
2023 Q2	$261K	Buy	+556	New	+$233K	0.08%	68

Other funds holding LLY

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

ONB

Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

GIM

Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

WAM

Weatherly Asset Management Del Mar, California $1.4B AUM 36.32% 1-Year Est. Return

CRM

Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return

VNIM

Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

Cypress Capital's LLY Position: Q2 2026 in Review

Cypress Capital reduced its Eli Lilly (LLY) stake by 0.8% in Q2 2026, selling an estimated $6.13K and leaving 746 shares worth $895K. The position accounts for 0.24% of the portfolio, ranked #59.

Cypress Capital first reported a position in LLY in Q2 2023 and has held it in 13 quarters since. The position peaked at $981K in Q2 2024. 943 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Cypress Capital held 746 shares of Eli Lilly worth $895K as of Q2 2026.
Cypress Capital sold 6 Eli Lilly shares in Q2 2026, an estimated $6.13K.
Eli Lilly made up 0.24% of Cypress Capital's portfolio in Q2 2026, its #59 holding.
Cypress Capital first reported a position in Eli Lilly in Q2 2023 and has held it in 13 quarters since.
Cypress Capital's Eli Lilly position peaked at $981K in Q2 2024.
943 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Cypress Capital's 13F filing for Q2 2026, filed 17 Jul 2026.